DJIA 17,683.58 -46.53 -0.26%
NASDAQ 4,991.94 0.00 0.00%
S&P 500 2,068.76 -8.02 -0.39%
market minute promo

United Therapeutics Corp (NASDAQ: UTHR)

170.88 0.77 (0.45%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

UTHR $170.88 0.45%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $169.21
Previous Close $170.11
Daily Range $168.31 - $172.15
52-Week Range $86.04 - $190.29
Market Cap $7.9B
P/E Ratio 48.74
Dividend (Yield) $0.00 (0.0%)
Volume 936,779
Average Daily Volume 603,850
Current FY EPS $7.08

Sector

Healthcare

Industry

Drug Makers

United Therapeutics Corp (UTHR) Description

A biotechnology company focused on the development and commercialization of innovative therapeutic products for patients with chronic and life-threatening cardiovascular, cancer and infectious diseases. Website: http://www.unither.com/

News & Commentary

Maverick Capital: Here's What This Hedge Fund Company Has Been Buying

Keeping up with Maverick Capital and other big investors can yield some insights and investment ideas.

Lessons Learned: Time To Simplify The Well-Valued Growth Portfolio

United Therapeutics Appears Undervalued

United Therapeutics Faces Patent Challenge for Tyvaso - Analyst Blog

United Therapeutics Corporation Receives Paragraph IV Notice Letter for Tyvaso

Top Mutual Funds Add To Medical Holdings

The Growth Portfolio Keeps On Growing

United Therapeutics Corporation - ZER Reports

United Therapeutics Corporation - ZER Reports

The Highest Paid CEOs in Biotech

These highest paid CEOs in biotech brought in a minimum of $24 million in compensation in 2014. Find out what makes these leaders so special, and whether or not their exorbitant pay packages are sustainable.

Jim Cramer's Top Takeaways: United Therapeutics, American Airlines, Wix.com

See More UTHR News...

UTHR's Top Competitors

UTHR $170.88 (0.45%)
Current stock: UTHR
AMGN $154.50 (0.81%)
Current stock: AMGN
GILD $115.66 (0.54%)
Current stock: GILD
BIIB $404.63 (0.09%)
Current stock: BIIB